Saturday, July 11, 2026

pharma · Non Small Cell Lung Cancer · Non-Small Cell Lung Cancer

Hunan Province Tumor

Hunan Province Tumor is a pharma organization headquartered in CN. Primary therapeutic focus areas include Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer. NovaPharmaNews links 2 clinical program(s), 0 drug profil

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
2
Drugs
5
Patents
0
Clinical program

Chemotherapy + immunotherapy

Phase 2 · small molecule · Non Small Cell Lung Cancer

Chemotherapy + immunotherapy for Non Small Cell Lung Cancer is a Phase 2 program (small_molecule) at Hunan Province Tumor Hospital with 1 ClinicalTrials.gov record(s).

Internal code RENO

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Hunan Province Tumor Hospital
Phase
Phase 2
Modality
small_molecule
Indication
Non Small Cell Lung Cancer
Status
active
Trials
1